SREBF1 and fatty liver disease: Such exposure has been shown to disrupt AMPK/PPARα-mediated fatty acid oxidation by inducing severe oxidative stress, mitochondrial dysfunction, endoplasmic reticulum stress, and inflammatory responses, while simultaneously upregulating SREBP-1c-driven lipid synthesis, ultimately driving hepatic steatosis and damage.